NPS Pharmaceuticals (NPSP) Misses Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NVDA
6. AMAT
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to NPS Pharmaceuticals (NPSP) Misses Q3 EPS by 3c

Canaccord Keeps NPS Pharma (NPSP) at 'Buy'; Some Centers Slower to Put Patients on Gattex

November 11, 2014 11:07 AM EST

Canaccord Genuity affirms NPS Pharmaceuticals (Nasdaq: NPSP) at Buy with a price target of $42 following Q3 results reported Monday night.

Analyst John Newman noted that Gattex growth of about 18.6 percent over Q2 was flat with expectations, but guidance of $100 to... More